You are now leaving the Kedrion Corporate site. The information available in your chosen website may not be in compliance with EU legislation regulating the advertising of medicinal products for human use, nor do the opinions expressed necessarily reflect the Company’s positions or are endorsed by it.
NO
YES
  • Slide Image

    Keep life flowing

    Kedrion’s plasma-derived therapies help people suffering from debilitating conditions like Hemophilia and Immune Deficiencies. We are privileged to provide this service and do so with a profound sense of responsibility.

  • Slide Image

    Keep life flowing

    Kedrion’s plasma-derived therapies help people suffering from debilitating conditions like Hemophilia and Immune Deficiencies. We are privileged to provide this service and do so with a profound sense of responsibility.

  • Slide Image

    Keep life flowing

    Kedrion’s plasma-derived therapies help people suffering from debilitating conditions like Hemophilia and Immune Deficiencies. We are privileged to provide this service and do so with a profound sense of responsibility.

  1. 1
  2. 2
  3. 3

News

CORPORATE

FSI SGR enters Kedrion share capital

The company continues with its growth and development strategy

read more 

CORPORATE

Kedrion submits to FDA for Manufacture of RhoGAM/MICRhoGAM in Melville, NY

read more 

EVENTS

Kedrion reaffirms its commitment for the global eradication of Rh disease

A worldwide initiative for maternal and fetal health launches in Florence, Italy

read more 

2018
ANNUAL REPORT

Kedrion hilite image
Kedrion hilite image
Kedrion hilite image